Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: Use, pitfalls, and new directions

American Heart Journal

Volumn 161, Issue 3, 2011, Pages 462-470

  Capodanno, Davide ^a,b   Tamburino, Corrado ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b ETNA Foundation   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ALGORITHM; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HUMAN; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; STROKE; SYSTEMATIC REVIEW; VALIDATION STUDY;

EID: 79952455721     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.11.018     Document Type: Review

References (31)

1. Sianos G., Morel M.A., and Kappetein A.P. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease EuroIntervention 1 2005 219 227
2. Serruys P.W., Morice M.C., and Kappetein A.P. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
3. American Heart Association Grading Committee Coronary artery disease reporting system Circulation 51 1975 31 33
4. Serruys P.W., Unger F., and van Hout B.A. The ARTS study (Arterial Revascularization Therapies Study) Semin Interv Cardiol 4 1999 209 219
5. Leaman D.M., Brower R.W., and Meester G.T. Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function Circulation 63 1981 285 299
6. Altman D.G., and Royston P. What do we mean by validating a prognostic model? Stat Med 19 2000 453 473 (Pubitemid 30126878)
7. Morice M.C., Serruys P.W., and Kappetein A.P. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) trial Circulation 121 2010 2645 2653
8. Maurice M.C. Impact of 2-year SYNTAX LM study Presented at: Transcatheter Therapeutics Asia Pacific; April 29, 2010; Seoul, South Korea 2010
9. Kim Y.K., Park D.W., and Kim W.J. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization J Am Coll Cardiol Intv 3 2010 612 623
10. Brito J., Teles R., and Sousa P. Predictive value of SYNTAX score in risk stratification of patients undergoing left main coronary artery angioplasty (abstr) Eurointervention 6 2010 H69
11. Capodanno D., Di Salvo M.E., and Cincotta G. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease Circ Cardiovasc Interv 2 2009 302 308
12. Nadra I. Does the SYNTAX score predict outcome following PCI to the left main coronary artery in the real world? Presented at: Transcatheter Therapeutics; September 24, 2009; Washington, DC 2009
13. Onuma Y., Girasis C., and Piazza N. Long-term clinical results following stenting of the left main stem J Am Coll Cardiol Intv 3 2010 584 594
14. Birim O., van Gameren M., and Bogers A.J. Complexity of coronary vasculature predicts outcome of surgery for left main disease Ann Thorac Surg 87 2009 1097 1104
15. Capodanno D., Capranzano P., and Di Salvo M.E. Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft JACC Cardiovasc Interv 2 2009 731 738
16. Lemesle G., Bonello L., and de Labriolle A. Prognostic value of the SYNTAX score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease Catheter Cardiovasc Interv 73 2009 612 617
17. Valgimigli M., Serruys P.W., and Tsuchida K. Cyphering the complexity of coronary artery disease using the SYNTAX score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention Am J Cardiol 99 2007 1072 1081 (Pubitemid 46562516)
18. Romagnoli E., Burzotta F., and Trani C. EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention Heart 95 2009 43 48
19. Kim Y.H., Ahn J.M., and Park D.W. EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting Am J Cardiol 98 2006 1567 1570
20. Capodanno D., Miano M., and Cincotta G. EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention Am Heart J 159 2010 103 109
21. Serruys P.W. Integrating lessons from recent clinical trials into practice: beyond the SYNTAX score Presented at: Transcatheter Therapeutics Asia Pacific; April 29, 2010; Seoul, South Korea 2010
22. Ranucci M., Castelvecchio S., and Menicanti L. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony Circulation 119 2009 3053 3061
23. Garg S., Sarno G., and Garcia-Garcia H.M. A new tool for the risk stratification of patients with coronary artery disease: the clinical SYNTAX score Circ Cardiovasc Interv 3 2010 317 326
24. Capodanno D, Caggegi A, Miano M., et al. Clinical SYNTAX score and Global Risk Classification in patients undergoing percutaneous or surgical left main revascularization. JACC Cardiovasc Interv [ahead of print]
25. Chen S.L., Chen J.P., and Mintz G. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting J Am Coll Cardiol Intv 3 2010 632 641
26. Feldman T. The SYNTAX score in practice: an aid for patient selection for complex PCI Catheter Cardiovasc Interv 73 2009 618 619
27. Garg S. Scores in multi-vessel disease patients: important tools for decision-making or just for trial purposes? Presented at EuroPCR; May 28, 2010; Paris, France 2010
28. Stone G.W. Motivation, objective and implication of EXCEL study Presented at: Transcatheter Therapeutics Asia Pacific; April 28, 2010; Seoul, South Korea 2010
29. Wykrzykowska J.J., Garg S., and Girasis C. Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial J Am Coll Cardiol 56 2010 272 277
30. Serruys P.W., Onuma Y., and Garg S. Assessment of the SYNTAX score in the SYNTAX study EuroIntervention 5 2009 50 56
31. Garg S., Girasis C., and Sarno G. The SYNTAX score revisited: a reassessment of the SYNTAX score reproducibility Catheter Cardiovasc Interv 75 2010 946 952